HIV Pre-Exposure Prophylaxis in Transgender Women: A Subgroup Analysis of the iPrEx Trial

    November 2015 in “ The Lancet HIV
    Madeline B. Deutsch, David V. Glidden, Jae Sevelius, JoAnne Keatley, Vanessa McMahan, Juan V. Guanira, Esper G. Kallas, Suwat Chariyalertsak, Robert M. Grant
    Image
    Studysummary This study observed that while PrEP was effective among transgender women if taken, adherence was low, especially among those at higher risk.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’